InvestorsHub Logo

the_hoard

04/01/19 10:34 AM

#3264 RE: Letterpenny #3263

This company still doesn't seem to have agreeable secured creditors. Thats going to slow things down. If the deal can't establish fair value, it'll take even longer. Audits aren't a fast process and they only filed in mid Feb. Bankruptcy laws are quite specific even if all parties are in agreement. It'd be faster for you to actually train hard and learn to slam dunk then to consider any part of this process a slam dunk.

Whats interesting to me is that the company debt is low here. Even at $12M - $18M its low. I've seen companies with $200M in debt get bought for $75M. Thats why this is an opportunity. Still looking at another 2 - 4 months. This thing should move on the 1st drugs PR and then again on the 2nd.

No partnerships. This company will cease operations after the sale closes.

Both deals could generate $40M - $80M in total. After all costs and payouts common shareholders should get something. Even if it heads up to 300+ OS.
---

One other tip padawan, redactions are like the veins to a major gold deposit in BK. Good sign. The hearing was open book for the most part. Offers & true value. Company names and timelines. If secured's agree, even better.